Sublingual atropine for the treatment of severe and hyoscine-resistant clozapine-induced sialorrhea.
Northamptonshire Healthcare NHS Foundation Trust, Northamptonshire, United Kingdom.
F A
FA
Mustafa
A
A
Khan
J
J
Burke
M
M
Cox
S
S
Sherif
D000286:Administration, Sublingual; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001285:Atropine / Q000008:administration & dosage*; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage; D012559:Schizophrenia / Q000188:drug therapy*; D012601:Scopolamine / Q000008:administration & dosage; D012798:Sialorrhea / Q000139:chemically induced / Q000188:drug therapy; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D018727:Muscarinic Antagonists; D001285:Atropine; D012601:Scopolamine; D003024:Clozapine